Cost-effectiveness of the CNIC-polypill strategy for the secondary prevention of CV disease in male and female patients with established coronary heart disease based on improved risk factor control

被引：0
|
作者：
Aguiar, C. [1 ]
Araujo, F. [2 ]
Rubio, G. [3 ]
Carcedo, D. [4 ]
Abreu-Oliveira, T. P. [5 ]
Paz, S. [6 ]
Castellano, J. M. [7 ]
Fuster, V. [8 ]
机构：
[1] Hosp Santa Cruz, Serv Cardiol, Carnaxide, Portugal
[2] Hosp Lusiadas, Serv Med Interna, Lisbon, Portugal
[3] Ferrer Int, Barcelona, Spain
[4] Hygeia Consulting, Madrid, Spain
[5] Ferrer Portugal, Lisbon, Portugal
[6] Smartwriting4u, Benicassim, Spain
[7] Natl Ctr Cardiovasc Res CNIC, Madrid, Spain
[8] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
来源：
EUROPEAN HEART JOURNAL | 2021年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2552 / 2552
页数：1
相关论文
共 39 条
  • [31] Machine learning-based prediction model construction and correlation analysis of continuous glucose monitoring factor CV and the risk of coronary heart disease in patients with type 2 diabetes
    Li, X.
    Feng, Z.
    Shao, J.
    DIABETOLOGIA, 2024, 67 : S509 - S510
  • [32] Cost effectiveness of treating high-risk individuals aged 45-65 years with statins in Germany for primary and secondary prevention of coronary heart disease from the perspective of the social security system
    Hinzpeter, B
    Klever-Deichert, G
    Lauterbach, KW
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 1999, 1 (0M) : M33 - M38
  • [33] Secondary prevention of high-risk patients with chronic coronary heart disease in the global STABILITY trial: excellent evidence-based therapy but improvement needed to reach goals
    Vedin, O.
    Hagstrom, E.
    Stewart, R.
    Brown, R.
    Krug-Gourley, S.
    Davies, R.
    Smith, P.
    Wallentin, L.
    White, H.
    Held, C.
    EUROPEAN HEART JOURNAL, 2011, 32 : 389 - 389
  • [34] Self-monitoring of blood glucose improved glycemic control and the 10-year coronary heart disease risk profile of female type 2 diabetes patients in Trinidad and Tobago
    Ezenwaka, C. E.
    Dimgba, A.
    Okali, F.
    Skinner, T.
    Extavour, R.
    Rodriguez, M.
    Jones-LeCointe, A.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2011, 14 (01) : 1 - 5
  • [35] Risk of fatal and nonfatal coronary heart disease and stroke events among adult patients with hypertension: basic Markov model inputs for evaluating cost-effectiveness of hypertension treatment: systematic review of cohort studies
    Sorato, Mende Mensa
    Davari, Majid
    Kebriaeezadeh, Abbas
    Sarrafzadegan, Nizal
    Shibru, Tamiru
    Fatemi, Behzad
    JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH, 2021, 12 (02) : 283 - 302
  • [36] Cost-effectiveness of coronary artery disease screening in asymptomatic patients with type 2 diabetes and other atherogenic risk factors in Japan: Factors influencing on international application of evidence-based guidelines
    Hayashino, Yasuaki
    Shimbo, Takuro
    Tsujii, Satoru
    Ishii, Hitoshi
    Kondo, Hirokazu
    Nakamura, Tsukasa
    Nagata-Kobayashi, Shizuko
    Fukui, Tsuguya
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 118 (01) : 88 - 96
  • [37] Cost-effectiveness of Atorvastatin plus Amlodipine versus Atorvastatin plus Atenolol in hypertensive patients without previous coronary heart disease, normal to mildly elevated cholesterol levels and at least 3 cardiovascular risk factors
    F Bobadilla, J.
    Merikle, E.
    Garcia, M.
    Darba, J.
    Sanchez, C.
    VALUE IN HEALTH, 2007, 10 (06) : A415 - A416
  • [38] Time Trends in Lifestyle, Risk Factor Control, and Use of Evidence-Based Medications in Patients With Coronary Heart Disease in Europe Results From 3 EUROASPIRE Surveys, 1999-2013
    Kotseva, Kornelia
    De Bacquer, Dirk
    Jennings, Catriona
    Gyberg, Viveca
    De Backer, Guy
    Ryden, Lars
    Amouyel, Philippe
    Bruthans, Jan
    Cifkova, Renata
    Deckers, Jaap W.
    De Sutter, Johan
    Fraz, Zlatko
    Graham, Ian
    Keber, Irena
    Lehto, Seppo
    Moore, David
    Pajak, Andrzej
    Wood, David
    GLOBAL HEART, 2017, 12 (04) : 315 - +
  • [39] Strategies for Primary Prevention of Coronary Heart Disease Based on Risk Stratification by the ACC/AHA Lipid Guidelines, ATP III Guidelines, Coronary Calcium Scoring, and C-Reactive Protein, and a Global Treat-All Strategy: A Comparative-Effectiveness Modeling Study
    Galper, Benjamin Z.
    Wang, Y. Claire
    Einstein, Andrew J.
    PLOS ONE, 2015, 10 (09):
1234